WBR253: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{WBRQuestion |QuestionAuthor=Gerald Chi |ExamType=USMLE Step 1 |MainCategory=Biochemistry, Pathology |SubCategory=Musculoskeletal/Rheumatology |MainCategory=Biochemistry, Pat...")
 
No edit summary
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor=Gerald Chi
|QuestionAuthor=Gerald Chi (Reviewed by {{YD}})
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Biochemistry, Pathology
|MainCategory=Biochemistry, Pathophysiology
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Musculoskeletal/Rheumatology
|MainCategory=Biochemistry, Pathology
|MainCategory=Biochemistry, Pathophysiology
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Musculoskeletal/Rheumatology
|MainCategory=Biochemistry, Pathology
|MainCategory=Biochemistry, Pathophysiology
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Musculoskeletal/Rheumatology
|MainCategory=Biochemistry, Pathology
|MainCategory=Biochemistry, Pathophysiology
|MainCategory=Biochemistry, Pathology
|MainCategory=Biochemistry, Pathophysiology
|MainCategory=Biochemistry, Pathophysiology
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Musculoskeletal/Rheumatology
|MainCategory=Biochemistry, Pathology
|MainCategory=Biochemistry, Pathophysiology
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Musculoskeletal/Rheumatology
|MainCategory=Biochemistry, Pathology
|MainCategory=Biochemistry, Pathophysiology
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Musculoskeletal/Rheumatology
|MainCategory=Biochemistry, Pathology
|MainCategory=Biochemistry, Pathophysiology
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Musculoskeletal/Rheumatology
|MainCategory=Biochemistry, Pathology
|MainCategory=Biochemistry, Pathophysiology
|MainCategory=Biochemistry, Pathology
|MainCategory=Biochemistry, Pathophysiology
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Musculoskeletal/Rheumatology
|Prompt=A 37-year-old female presents with malaise, proxmial muscle weakness, and swollen hand and knee joints. She also reports dry eye and dry mouth. When exposed to cold temperatures, her fingers become pallor and cyanotic and turn red and tingle. Physical examination shows scaly erythematous eruptions overlying the knuckles and elbows. Laboratory findings include lymphopenia with mild anemia and thrombocytopenia. A diagnosis is made by the presence of speckled anti-nuclear antibody as well as of a certain type of autoantibodies against extractable nuclear antigens. Which of the following structures is most likely to be the target of the antibodies?
|Prompt=A 37-year-old woman presents with malaise, proxmial muscle weakness, and swollen hand and knee joints. She also reports dry eyes and dry mouth. When exposed to cold temperatures, her fingers become pale and cyanotic and turn red and numb. Physical examination is remarkable for scaly erythematous eruptions overlying the knuckles and elbows. Laboratory findings demonstrate lymphopenia with mild anemia and thrombocytopenia. A diagnosis is then made following the detection of speckled anti-nuclear antibody as well as autoantibodies against extractable nuclear antigens. Which of the following structures is most likely to be the target of the antibodies?
 
|Explanation=Mixed connective tissue disease (MCTD) combines features of scleroderma, myositis, systemic lupus erythematosus, and rheumatoid arthritis and is thus considered an overlap syndrome. MCTD commonly manifests with joint pain/swelling, malaise, Raynaud phenomenon, Sjögren's syndrome, muscle inflammation, and sclerodactyly. Distinguishing laboratory characteristics are a positive, speckled anti-nuclear antibody and an anti-U1-RNP antibody.
|Explanation=Mixed connective tissue disease combines features of scleroderma, myositis, systemic lupus erythematosus, and rheumatoid arthritis and is thus considered an overlap syndrome. MCTD commonly causes joint pain/swelling, malaise, Raynaud phenomenon, Sjögren's syndrome, muscle inflammation, and sclerodactyly. Distinguishing laboratory characteristics are a positive, speckled anti-nuclear antibody and an anti-U1-RNP antibody.
|AnswerA=Transfer RNA (tRNA)
|AnswerA=Transfer RNA (tRNA)
 
|AnswerAExp=Anti-U1-RNP antibody does not target tRNA.
|AnswerAExp='''Incorrect'''<BR>Anti-U1-RNP antibody does not target tRNA
|AnswerB=Small interfering RNA (siRNA)
|AnswerB=Small interfering RNA (siRNA)  
|AnswerBExp=Anti-U1-RNP antibody does not target siRNA
 
|AnswerBExp='''Incorrect'''<BR>Anti-U1-RNP antibody does not target siRNA
|AnswerC=Small nuclear ribonucleoprotein (snRNP)
|AnswerC=Small nuclear ribonucleoprotein (snRNP)
|AnswerCExp='''Correct'''<BR>Anti-U1-RNP antibody targets snRNP, which is a complex of snRNA (produced by RNAP II) and multiple proteins.
|AnswerCExp=Anti-U1-RNP antibody targets snRNP, which is a complex of snRNA (produced by RNAP II) and multiple proteins.
 
|AnswerD=Heterogeneous nuclear RNA (hnRNA)
|AnswerD=Heterogeneous nuclear RNA (hnRNA)
 
|AnswerDExp=Anti-U1-RNP antibody does not target hnRNA. The snRNP combines with hnRNA to form spliceosome and undergoes splicing.
|AnswerDExp='''Incorrect'''<BR>Anti-U1-RNP antibody does not target hnRNA. The snRNP combines with hnRNA to form spliceosome and undergoes splicing.
|AnswerE=Deoxyribonucleic acid (DNA)
|AnswerE=Deoxyribonucleic acid (DNA)
 
|AnswerEExp=Anti-U1-RNP antibody does not target DNA.
|AnswerEExp='''Incorrect'''<BR>Anti-U1-RNP antibody does not target DNA
|EducationalObjectives=Anti-U1-RNP antibodies are often elevated in patients with mixed connective tissue disease. Anti-U1-RNP antibody targets snRNP, which is a complex of snRNA (produced by RNAP II) and multiple proteins.
|References=Ghirardello A, Doria A, Vesco P, et al. Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease. Rheumatol Int. 1996;16(4):145-50.<br>
First Aid 2015 page 213.
|RightAnswer=C
|RightAnswer=C
|Approved=No
|WBRKeyword=Anti-U1-RNP antibody, Mixed connective tissue disease, MCTD, Small nuclear ribonucleoprotein
|Approved=Yes
}}
}}

Revision as of 01:05, 17 August 2015

 
Author [[PageAuthor::Gerald Chi (Reviewed by Yazan Daaboul, M.D.)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Biochemistry, MainCategory::Pathophysiology
Sub Category SubCategory::Musculoskeletal/Rheumatology
Prompt [[Prompt::A 37-year-old woman presents with malaise, proxmial muscle weakness, and swollen hand and knee joints. She also reports dry eyes and dry mouth. When exposed to cold temperatures, her fingers become pale and cyanotic and turn red and numb. Physical examination is remarkable for scaly erythematous eruptions overlying the knuckles and elbows. Laboratory findings demonstrate lymphopenia with mild anemia and thrombocytopenia. A diagnosis is then made following the detection of speckled anti-nuclear antibody as well as autoantibodies against extractable nuclear antigens. Which of the following structures is most likely to be the target of the antibodies?]]
Answer A AnswerA::Transfer RNA (tRNA)
Answer A Explanation AnswerAExp::Anti-U1-RNP antibody does not target tRNA.
Answer B AnswerB::Small interfering RNA (siRNA)
Answer B Explanation AnswerBExp::Anti-U1-RNP antibody does not target siRNA
Answer C AnswerC::Small nuclear ribonucleoprotein (snRNP)
Answer C Explanation AnswerCExp::Anti-U1-RNP antibody targets snRNP, which is a complex of snRNA (produced by RNAP II) and multiple proteins.
Answer D AnswerD::Heterogeneous nuclear RNA (hnRNA)
Answer D Explanation AnswerDExp::Anti-U1-RNP antibody does not target hnRNA. The snRNP combines with hnRNA to form spliceosome and undergoes splicing.
Answer E AnswerE::Deoxyribonucleic acid (DNA)
Answer E Explanation AnswerEExp::Anti-U1-RNP antibody does not target DNA.
Right Answer RightAnswer::C
Explanation [[Explanation::Mixed connective tissue disease (MCTD) combines features of scleroderma, myositis, systemic lupus erythematosus, and rheumatoid arthritis and is thus considered an overlap syndrome. MCTD commonly manifests with joint pain/swelling, malaise, Raynaud phenomenon, Sjögren's syndrome, muscle inflammation, and sclerodactyly. Distinguishing laboratory characteristics are a positive, speckled anti-nuclear antibody and an anti-U1-RNP antibody.

Educational Objective: Anti-U1-RNP antibodies are often elevated in patients with mixed connective tissue disease. Anti-U1-RNP antibody targets snRNP, which is a complex of snRNA (produced by RNAP II) and multiple proteins.
References: Ghirardello A, Doria A, Vesco P, et al. Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease. Rheumatol Int. 1996;16(4):145-50.
First Aid 2015 page 213.]]

Approved Approved::Yes
Keyword WBRKeyword::Anti-U1-RNP antibody, WBRKeyword::Mixed connective tissue disease, WBRKeyword::MCTD, WBRKeyword::Small nuclear ribonucleoprotein
Linked Question Linked::
Order in Linked Questions LinkedOrder::